Thermo Fisher Scientific

Thermo Fisher Scientific expands its SARS-CoV-2 testing portfolio in India with a point-of-care testing platform

Thermo Fisher Scientific expands its SARS-CoV-2 testing portfolio in India with a point-of-care testing platform

The Accula System is an innovative platform that will accelerate the availability of reliable and accurate advanced molecular diagnostics at the point of care. Mumbai (Maharashtra) [India], June 15: Thermo Fisher Scientific today announced the introduction of the new and innovative Accula SARS-CoV-2 Test that delivers gold-standard reverse transcription-polymerase chain reaction (RT-PCR) detection of SARS-CoV-2 in a point-of-care format. The Accula SARS-CoV-2 Test has received Emergency Use Authorization (EUA) from the United States (U.S.) Food and Drug Administration (FDA) for the detection of SARS-CoV-2 in Clinical Laboratory Improvement Amendments (CLIA)–waived environments. “Since the start of the pandemic, Thermo Fisher has acted…
Read More
Thermo Fisher Scientific commits $10 million to support India’s fight against COVID-19

Thermo Fisher Scientific commits $10 million to support India’s fight against COVID-19

Mumbai (Maharashtra) [India], May 12: Thermo Fisher Scientific, the world leader in serving science, has pledged $10 million as its contribution to India’s fight against COVID-19. As COVID-19 cases continue to escalate, this support aims to offer cash and urgently needed products to help the country in bringing the health crisis under control. As part of the commitment, the company is directing more than $1 million to non-governmental and non-profit organizations that are directly serving the people impacted by the pandemic. The remaining $9 million donations are extended in the form of COVID-19 testing products, personal protective equipment, and other…
Read More